Intestinal and tumor microbiome analysis combined with metabolomics of the anti-PD-L1 phase II PERFECT trial for resectable esophageal adenocarcinoma.

Nicolien C. de Clercq, Max Nieuwdorp, Andrei Prodan et al.|Journal of Clinical Oncology|2020

Cited by 1